House Passes US OTC Monograph Reform And Committee Clears HSA Change
Executive Summary
Next step for OTC monograph reform legislation is Senate consideration; market exclusivity periods are likely focus of House/Senate conference. Separate bill to allow consumers to use health savings accounts to buy OTC drugs without a doctor's prescription clears House Ways and Means panel.
You may also be interested in...
House Maintains Momentum For US OTC Monograph Reform, But Senate Remains A Question Mark
With a new US Congress just convening, OTC monograph reform advocates face an old problem: the need for Senate action. The House has already cleared an OTC reform measure, as part of a pandemic preparedness bill, in the first days of the legislative session.
US FDA's Sunscreen Progress Gets Dim Review From Congressional Appropriators
House and Senate appropriators' take note that US FDA has not approved an additional OTC sunscreen ingredient since the 2014 passage of the Sunscreen Innovation Act.
US FDA's Sunscreen Progress Gets Dim Review From Congressional Appropriators
House and Senate appropriators' take note that US FDA has not approved an additional OTC sunscreen ingredient since the 2014 passage of the Sunscreen Innovation Act.